Is Your Practice Ready for the Impact of Theranostics?

Nuclear theranostics, combined with hybrid imaging (SPECT/CT, PET/CT, PET/MR), are playing a major role in precision medicine, significantly improving disease management—particularly in oncology. Delivered by international leaders in nuclear radiology, this comprehensive symposium on Thursday, August 11, 2022 will detail current and future roles for theranostics in imaging, particularly for patients suffering from neuroendocrine and prostate cancers.

The practice of a fully integrated diagnostic and therapeutic medical imaging specialty requires in-depth knowledge of many different fields of medicine and complex imaging equipment, alongside understanding of patient management and health care system economics. Therefore, “Is Your Practice Ready for the Impact of Theranostics?” will provide both clinical knowledge and financial tips for setting up a theranostics practice.
  • Earn up to 4.5 CME/Live SA-CME credits during and after the presentation through August 11, 2023
  • Gain insights into current and future roles for theranostics in patient outcomes
  • Learn from accomplished faculty
  • Access session recordings and credit claiming for one year
View Schedule


Faculty

Course Director


Jean-Luc Urbain, MD, PhD, CPE, FASNC
Professor of Radiology-Nuclear Medicine/Cardiology
Chief & Medical Director Nuclear Medicine
Wake Forest University
Atrium Health Wake Forest Baptist

Course Faculty


Prof. Andrew Scott
Olivia Newton-John Cancer Research Institute 
Melbourne, Australia

Homer Macapinlac, MD
MD Anderson Cancer Center
Houston, TX
 

Heather Jacene, MD
Dana-Farber Cancer Institute
Boston, MA
 

Gholam Reza Berenji, MD
Clinical Professor of Radiology
UCLA/ VA Greater Los Angeles
 
 

Pat Zanzonico, PhD, DABR
Memorial Sloan Kettering Cancer Center
New York, NY
 

Gang Niu, MD, PhD
U.S. Food and Drug Administration 
Bethesda, MD 
 

Daniel J. Lee, MD
Ochsner Medical Center
New Orleans, LA

Reggie Munden, MD, DMD, MBA
Medical University of South Carolina
Charleston, SC 
 
 

The American Roentgen Ray Society (ARRS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education activities for physicians. 
Is Your Practice Ready for the Impact of Theranostics?: ARRS designates this live activity for a maximum of 4.50 AMA PRA Category 1 Credit(s)™ and 4.50 American Board of Radiology, MOC Part II, live Self-Assessment (SA-CME) credits. Physicians should claim only the credit commensurate with the extent of their participation in an activity. 
Credit On-Demand Sessions: ARRS designates this enduring material for a maximum of 4.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ARRS has “Deemed Status” with the American Board of Radiology (ABR) Maintenance of Certificate Program. This activity is also qualified by the American Board of Radiology in meeting the criteria for self-assessment toward the purpose of fulfilling requirements in the ABR Maintenance of Certification Program.